B-CELL LEUKEMIA
Clinical trials for B-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch CAR-T trial offers hope for kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a new, experimental CAR-T cell therapy designed to fight two targets (CD19 and CD22) on cancer cells at once. It is for children and young adults (ages 3-39) whose B-cell leukemia or lymphoma has come back or hasn't responded to standard treatments. Doctors …
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New 'Off-the-Shelf' cancer treatment trial offers hope for patients who have run out of options
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called universal CAR-T (UWD-CD19) for people with B-cell cancers like lymphoma or leukemia that have come back or not responded to standard treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor…
Matched conditions: B-CELL LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New 'Living Drug' trial offers hope for tough blood cancers
Disease control Recruiting nowThis is a first-in-human safety study testing a new personalized cell therapy called CLIC-2201. It is for adults and children with B-cell blood cancers (like leukemia and lymphoma) that have returned or not responded to other treatments. The main goal is to find the safest and mo…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Do cancer drugs wipe out Kids' vaccine shields? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if a common leukemia treatment called blinatumomab weakens the protection from childhood vaccines. Researchers will check antibody levels in up to 300 young patients (under 21) who have been treated for B-cell leukemia. They want to see if these pati…
Matched conditions: B-CELL LEUKEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC